File Download

There are no files associated with this item.

Supplementary

Conference Paper: Towards remyelination therapy with oligodendrocyte precursor and Schwann cells derived from bone marrow stromal cells

TitleTowards remyelination therapy with oligodendrocyte precursor and Schwann cells derived from bone marrow stromal cells
Authors
KeywordsSchwann Cell
Oligodendrocyte
Issue Date2013
PublisherSociety for Neuroscience.
Citation
The 43rd Annual Meeting of the Society for Neuroscience (SfN), San Diego, California, USA, 9-13 November 2013 How to Cite?
AbstractMyelin damage and disorders caused by injuries or diseases result in neuronal death and severe loss of function. With an aim to generate peripheral and central glial cells for remyelination therapy, we attempted to direct differentiation of bone marrow stromal cells (BMSCs, adult rats) along the oligodendroglial and Schwann cell lineages in vitro. BMSCs were maintained in sphere cultures until they expressed markers of neural progenitors. Then adherent culture supplemented with β-heregulin, PDGF-AA and bFGF induced differentiation of sphere cells into oligodendrocyte precursors (positive for NG2, Olig2, PDGFRa and Sox10). Alternatively, coculture of sphere cells with purified dorsal root ganglia (DRG) neurons in adherent culture supplemented with β-heregulin, PDGF-AA, bFGF and forskolin yielded fate-committed Schwann cells (positive for p75 and S100β). We hypothesize therefore that signals from DRG neurons switched the neural progenitors from the oligodendroglial fate to the Schwann cell fate. Myelinating function of these BMSC-derived glial cells was tested in co-culture with purified DRG neurons. In 2 weeks of coculture, BM-OPCs matured into oligodendrocytes and extended myelin basic protein (MBP)-positive processes along multiple axons. Vitamin C was required in the coculture with BM-SchCs for alignment with axons to develop into MBP-positive myelinated internodes. Our findings indicate BMSCs as a possible source of both OPCs and Schwann cells for remyelination therapy. [HKRGC GRF 777810M]
DescriptionPoster session 414: Stem Cell Based Disease Models
Program#414.09 & Poster#C10
Fulltext of the abstract in: http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=ae15cec6-2dcc-4422-8ace-28fa2a5f5708&cKey=30eeca4a-b146-4e82-b822-71354c17a0ce&mKey=8d2a5bec-4825-4cd6-9439-b42bb151d1cf
Persistent Identifierhttp://hdl.handle.net/10722/203792

 

DC FieldValueLanguage
dc.contributor.authorShum, DKYen_US
dc.contributor.authorTsui, YPen_US
dc.contributor.authorTai, WYEen_US
dc.contributor.authorChan, YSen_US
dc.date.accessioned2014-09-19T16:41:05Z-
dc.date.available2014-09-19T16:41:05Z-
dc.date.issued2013en_US
dc.identifier.citationThe 43rd Annual Meeting of the Society for Neuroscience (SfN), San Diego, California, USA, 9-13 November 2013en_US
dc.identifier.urihttp://hdl.handle.net/10722/203792-
dc.descriptionPoster session 414: Stem Cell Based Disease Models-
dc.descriptionProgram#414.09 & Poster#C10-
dc.descriptionFulltext of the abstract in: http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=ae15cec6-2dcc-4422-8ace-28fa2a5f5708&cKey=30eeca4a-b146-4e82-b822-71354c17a0ce&mKey=8d2a5bec-4825-4cd6-9439-b42bb151d1cf-
dc.description.abstractMyelin damage and disorders caused by injuries or diseases result in neuronal death and severe loss of function. With an aim to generate peripheral and central glial cells for remyelination therapy, we attempted to direct differentiation of bone marrow stromal cells (BMSCs, adult rats) along the oligodendroglial and Schwann cell lineages in vitro. BMSCs were maintained in sphere cultures until they expressed markers of neural progenitors. Then adherent culture supplemented with β-heregulin, PDGF-AA and bFGF induced differentiation of sphere cells into oligodendrocyte precursors (positive for NG2, Olig2, PDGFRa and Sox10). Alternatively, coculture of sphere cells with purified dorsal root ganglia (DRG) neurons in adherent culture supplemented with β-heregulin, PDGF-AA, bFGF and forskolin yielded fate-committed Schwann cells (positive for p75 and S100β). We hypothesize therefore that signals from DRG neurons switched the neural progenitors from the oligodendroglial fate to the Schwann cell fate. Myelinating function of these BMSC-derived glial cells was tested in co-culture with purified DRG neurons. In 2 weeks of coculture, BM-OPCs matured into oligodendrocytes and extended myelin basic protein (MBP)-positive processes along multiple axons. Vitamin C was required in the coculture with BM-SchCs for alignment with axons to develop into MBP-positive myelinated internodes. Our findings indicate BMSCs as a possible source of both OPCs and Schwann cells for remyelination therapy. [HKRGC GRF 777810M]-
dc.languageengen_US
dc.publisherSociety for Neuroscience.-
dc.relation.ispartofNeuroscience 2013en_US
dc.rightsNeuroscience 2013. Copyright © Society for Neuroscience.-
dc.subjectSchwann Cell-
dc.subjectOligodendrocyte-
dc.titleTowards remyelination therapy with oligodendrocyte precursor and Schwann cells derived from bone marrow stromal cellsen_US
dc.typeConference_Paperen_US
dc.identifier.emailShum, DKY: shumdkhk@hkucc.hku.hken_US
dc.identifier.emailTsui, YP: alex2013@hku.hken_US
dc.identifier.emailChan, YS: yschan@hku.hken_US
dc.identifier.authorityShum, DKY=rp00321en_US
dc.identifier.authorityChan, YS=rp00318en_US
dc.identifier.hkuros238209en_US
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats